(Q22254246)

positive regulation of cell population proliferation

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

1 reference

9

A Caignard

Anne

Caignard

1 reference

6 February 2023

G Carayol

1

Géraldine

Carayol

1 reference

6 February 2023

J Giron-Michel

2

Julien

Giron-Michel

1 reference

6 February 2023

B Azzarone

3

Bruno

Azzarone

1 reference

6 February 2023

L Castagna

4

Luca

Castagna

1 reference

6 February 2023

N Cambier

5

Nathalie

Cambier

1 reference

6 February 2023

Z Mishal

6

Zohar

Mishal

1 reference

6 February 2023

J H Bourhis

7

Jean-Henri

Bourhis

1 reference

6 February 2023

S Chouaib

8

Salem

Chouaib

1 reference

IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops

6 February 2023

language of work or name

English

0 references

publication date

25 May 2000

0 references

published in

Oncogene

0 references

volume

19

0 references

issue

23

0 references

page(s)

2758-66

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

A potential role for interleukin-15 in the regulation of human natural killer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

The NF-kappaB binding site is essential for transcriptional activation of the IL-15 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Interferon-alpha therapy for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

inferred from DOI database lookup

7 January 2021

based on heuristic

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

inferred from DOI database lookup

7 January 2021

based on heuristic

Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203584

inferred from DOI database lookup

7 January 2021

based on heuristic

Human Monocytes Constitutively Express Membrane-Bound, Biologically Active, and Interferon-γ–Upregulated Interleukin-15

1 reference

18 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1182/BLOOD.V93.10.3531.410K32_3531_3539

Identifiers

DOI

10.1038/SJ.ONC.1203584

0 references